Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Analyses of the FranceCoag cohort support differences in immunogenicity among one plasma-derived and two recombinant factor VIII brands in boys with severe hemophilia A.
Calvez T, Chambost H, d'Oiron R, Dalibard V, Demiguel V, Doncarli A, Gruel Y, Huguenin Y, Lutz P, Rothschild C, Vinciguerra C, Goudemand J; for FranceCoag Collaborators. Calvez T, et al. Haematologica. 2018 Jan;103(1):179-189. doi: 10.3324/haematol.2017.174706. Epub 2017 Oct 12. Haematologica. 2018. PMID: 29025913 Free PMC article.
FranceCoag: a 22-year prospective follow-up of the national French cohort of patients with inherited bleeding disorders.
Doncarli A, Demiguel V, Guseva Canu I, Goulet V, Bayart S, Calvez T, Castet S, Dalibard V, Demay Y, Frotscher B, Goudemand J, Lambert T, Milien V, Oudot C, Sannié T, Chambost H; FranceCoag Network. Doncarli A, et al. Eur J Epidemiol. 2019 May;34(5):521-532. doi: 10.1007/s10654-018-0468-7. Epub 2018 Dec 5. Eur J Epidemiol. 2019. PMID: 30515664
Clinical phenotype, fibrinogen supplementation, and health-related quality of life in patients with afibrinogenemia.
Casini A, von Mackensen S, Santoro C, Djambas Khayat C, Belhani M, Ross C, Dorgalaleh A, Naz A, Ünal E, Abdelwahab M, Lozeron ED, Trillot N, Susen S, Peyvandi F, de Moerloose P; QualyAfib Study Group. Casini A, et al. Blood. 2021 Jun 3;137(22):3127-3136. doi: 10.1182/blood.2020009472. Blood. 2021. PMID: 33512441 Free article. Clinical Trial.
Afibrinogenemia with two compound heterozygous mutations in FGA gene.
Feugray G, Billoir P, Casini A, Neerman-Arbez M, Barbay V, Chamouni P, Schneider P, Le Cam Duchez V. Feugray G, et al. Among authors: barbay v. Haemophilia. 2021 Sep;27(5):e641-e644. doi: 10.1111/hae.14377. Epub 2021 Jul 13. Haemophilia. 2021. PMID: 34255402 No abstract available.
Evaluation of thrombin generation assay in factor XI deficiency.
Kasonga F, Feugray G, Chamouni P, Barbay V, Fresel M, Chretien MH, Brunel S, Le Cam Duchez V, Billoir P. Kasonga F, et al. Among authors: barbay v. Clin Chim Acta. 2021 Dec;523:348-354. doi: 10.1016/j.cca.2021.10.021. Epub 2021 Oct 17. Clin Chim Acta. 2021. PMID: 34670127
Factor XII deficiency evaluated by thrombin generation assay.
Feugray G, Kasonga F, Chamouni P, Barbay V, Fresel M, Hélène Chretien M, Brunel S, Le Cam Duchez V, Billoir P. Feugray G, et al. Among authors: barbay v. Clin Biochem. 2022 Feb;100:42-47. doi: 10.1016/j.clinbiochem.2021.11.014. Epub 2021 Nov 26. Clin Biochem. 2022. PMID: 34843733 Clinical Trial.
35 results